Log in or Sign up for Free to view tailored content for your specialty!
Food Allergy News
Q&A: Company seeks to expand neffy FDA approval to more pediatric patients
ARS Pharmaceuticals announced its submission of a supplemental new drug application to the FDA for neffy 1 mg for the treatment of type 1 allergic reactions in children who weigh between 33 lb and 66 lb.
Food allergy prevalence doubled in Japan from 2010 to 2019
The prevalence of food allergy surged between 2010 and 2019 in Japan, increasing 1.7 times among children aged 6 years and younger, according to a study in Pediatric Allergy and Immunology.
Milk ladder therapy successful in mediating cow’s milk allergy
Dietary advancement therapy using a milk ladder shows that cow’s milk can be safely reintroduced to infants with a cow’s milk allergy, according to a study in Pediatric Allergy and Immunology.
Log in or Sign up for Free to view tailored content for your specialty!
Access to care, education may improve early introduction of allergens into infant diets
SAN ANTONIO — Despite evidence and guidelines, obstacles remain in the prompt introduction of allergenic foods into infant diets, Michael Pistiner, MD, MMSc, told Healio at the 16th Annual Allergy, Asthma & Immunology CME Conference.
GA2FA 2024 inspires attendees to think ‘inside the box’ to advance food allergy treatment
The Global Allergy and Asthma Excellence Network, or GA2LEN, will host its biannual global meeting from Sept. 5 to 7.
Top news of August: FDA neffy approval, women’s asthma health, APA-AAI conference, more
Healio has compiled August’s most-read news in asthma and allergy.
Q&A: Xolair ‘Accidents Happen’ ad campaign aims to help food allergy management
Despite daily vigilance in managing food allergies, everything does not always go according to plan.
Young people feel uneasy managing their allergy around peers, prefer family
Adolescents and young adults reported being less comfortable managing their allergy around their peers than with their families, according to a study published in The Journal of Allergy and Clinical Immunology.
Do we need more pharma or more farms to treat food allergies?
The field of food allergy treatment has been evolving rapidly, with several promising developments in recent years. Typically, much of what makes headlines, though, surrounds who pays for the headlines.
Q&A: DBV Technologies announces progress on Viaskin Peanut patch
DBV Technologies recently provided updates on its Viaskin Peanut Program for children and toddlers, announcing recruitment for the VITESSE study and progress in the COMFORT Toddlers supplemental safety study.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read